Overall survival with Nivolumab for patients with advanced, previously treated renal cell carcinoma United States

Authors:

Sullivan W, Lee D, Willis A, Doan J, Gooden K and Sowdani A.

Publication type:

Conference Proceedings – Poster

Publication name:

22nd International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual International meeting

Citation:

Sullivan W, Lee D, Willis A, Doan J, Gooden K and Sowdani A. Overall survival with Nivolumab for patients with advanced, previously treated renal cell carcinoma. 22nd International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual International meeting. Boston, MA, USA. 20 -24 May. Poster PCN52.

Link to publication ⟶

h4>⟵ Back to Search Results

By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies
By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies